An official website of the United States government
Home
Name
Treosulfan
Alternate Names
Grafapex
Abbreviations
None
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
39069
Primary Site
ALL
AML
MDS
Histology
None
Remarks
January 22, 2025 FDA approved Grafapex (treosulfan), an alkylating agent, with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation in adult and pediatric patients one year of age and older with acute myeloid leukemia or myelodysplastic syndrome
Coding
This drug should NOT be coded
